Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,932,676
+$224,550 QoQ
Shares Held
462,768
-2.9% QoQ
Ownership
0.478%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#45
of 314 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. XENE ranks #28 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in XENE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,932,676 | 462,768 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $27,708,126 | 476,494 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $18,707,957 | 417,402 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $15,924,935 | 396,636 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $12,414,706 | 396,636 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $15,253,507 | 454,650 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,293,495 | 492,181 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $18,262,207 | 463,861 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,346,385 | 521,836 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $24,146,056 | 560,884 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $24,452,517 | 530,884 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,467,237 | 569,884 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $27,176,534 | 705,884 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $25,740,382 | 719,206 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $29,015,906 | 735,884 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $27,467,912 | 760,884 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,256,718 | 863,140 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $18,472,044 | 604,254 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $16,573,163 | 530,511 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $10,936,232 | 715,722 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $13,326,743 | 715,722 | Shares | Sole | 2021-07-20 | |
| No filing history on record for this holder in this stock. | ||||||